IS IT TIME FOR DELIVERY? MANAGING PERSISTENT CATEGORY II FETAL HEART RATE TRACINGS
In this blog I’ll highlight a case scenario specific to intrapartum management of a persistent Category II fetal heart rate (FHR) tracing. The longitudinal evolution of the tracing will be highlighted as well as the perinatal care delivery responses. In closing, I’ll offer current recommendations regarding the management of persistent Category II FHR tracings with high-risk findings.
Case Scenario: Persistent Category II FHR Tracing
Patient Profile: A woman in active labor whose FHR tracing changes from Category I to Category II. Labor is being augmented with Oxytocin. Position change is the only documented intervention.
Tracing Observations: The fetal monitor shows a baseline FHR of 130 bpm, moderate variability, accelerations absent and intermittent late decelerations. A normal contraction pattern is observed.
Obstetrical provider order, note and plan of care: increase Pitocin as reassured by moderate variability.
Four hours later: The fetal monitor shows a baseline of 140 bpm, moderate variability, absent accelerations, recurrent late decelerations with intermittent variable decelerations and one prolonged deceleration.

(Image: Category II FHR tracing with late decelerations)
Birth Outcome: Vaginal birth of viable newborn requiring resuscitative efforts. Apgar scores: 2/4/6/6. Arterial cord blood gas: pH 6.9, BE -14. Transferred to NICU requiring therapeutic hypothermia for moderate to severe encephalopathy.
Comments: Prolonged or repetitive intrapartum fetal hypoxemia can lead to fetal acidemia. Fetal acidemia is associated with adverse neonatal outcomes, including encephalopathy and cerebral palsy.
Category II FHR tracings are the most common pattern associated with perinatal litigation claims involving hypoxic ischemic encephalopathy. Category II FHR tracings present with much heterogeneity, meaning, the presence of a broad range of patterns with various risk levels for the fetus. This can make it difficult to determine if the Category II tracing is indicative of current or impending fetal acidemia. This is why it’s crucial for all members of the perinatal team to further characterize the features of a Category II FHR, as well as the development of certain features over time. Characteristics of FHR tracings that are considered high risk, meaning, those features that have a greater likelihood of indicating fetal hypoxia or acidemia, are referenced below:
- Absent baseline FHR variability
- Prolonged, otherwise unexplained, minimal variability
- Unexplained change in baseline from normal to tachycardia
- Recurrent late, recurrent variable, or more than one prolonged deceleration
It’s important to be aware that currently, there is insufficient high-quality data to support the presence of moderate variability and / or fetal accelerations as markers of fetal well-being in the presence of Category II FHR tracings with high-risk features.
Recommended Management: In the setting of a persistent Category II FHR tracing, intrauterine resuscitation is required – maternal position change, amnioinfusion for variable decelerations, intravenous fluid bolus, discontinuation of augmentation or induction agents, oxygen, correction of maternal pathophysiology thought to be associated with the FHR tracing changes. Communication with the attending obstetrical provider is warranted.
The perinatal care team should also systematically consider individual characteristics of the hospital, available staff, patient, fetus and labor. Consideration must be made specific to labor progress, proximity to delivery, as well as maternal, fetal and labor risk factors when determining a management plan and timing of delivery.
If the above conservative resuscitative measures are unsuccessful, the obstetrical provider must decide whether to wait for spontaneous vaginal birth or to expedite delivery by other means (operative birth if appropriate, or cesarean section). This decision requires clinical judgment, weighing the estimated time until vaginal birth against the estimated time until the onset of potential injury.
In 2013 Clark et al. proposed a standardized approach to managing persistent Category II FHR tracings, as outlined below:
- Moderate variability or accelerations in the presence of significant decelerations with normal labor progress: expectant management with close observation regardless of the presence of decelerations. Exception: presence of prolonged decelerations
- Moderate variability or accelerations in the presence of significant decelerations with abnormal labor progress: cesarean section should be considered
- Absent moderate variability and accelerations with recurrent significant decelerations with failure to respond to above corrective measures for 30 minutes: delivery should be considered
- Absent moderate variability and accelerations in the absence of significant decelerations: delivery should be considered after 60 minutes if not responsive to interventions
In 2018 the Clark Algorithm was produced which describes a standardized approach to managing Category II FHR tracings with recurrent significant FHR decelerations based on FHR baseline variability. Significant decelerations are defined as late decelerations, variable decelerations lasting 60 seconds and reaching a nadir of ≤ 60 bpm or at least 60 bpm below baseline, or prolonged decelerations. See referenced algorithm below:

Closing Thoughts: Category II FHR tracings are the most complex to analyze and to manage. In the setting of persistent Category II FHR tracings, a common, preventable error in management is to postpone expedited delivery in the hope that the FHR tracing will resolve spontaneously. To reduce adverse outcomes as well as liability risk, efforts should be made to timely identify and treat Category II FHR tracings. In the setting of a clinical indication to expedite delivery, effort should be made to refrain from delaying decisions that are required to be made.
References
AAP, ACOG, 2017. Guidelines for Perinatal Care
ACOG, 2025. Intrapartum Fetal Heart Monitoring: Interpretation and Management
Miller et al., 2027. Pocket Guide to Fetal Monitoring
COMMENT AND SHARE: Do you anticipate a change in the way you interpret and / or manage persistent Category II FHR tracings following review of this post?


